Heart Transplantation for Amyloid Cardiomyopathy Has Comparable Outcomes With Other Etiologies: The UNOS Database
The number of heart transplants for ACM has increased in recent years, and overall outcomes in these ACM transplants have been similar compared to those for other cardiomyopathies. Despite historical concerns regarding poor prognosis and amyloid recurrence, carefully screened ACM patients can benefit from heart transplantation. Further research and optimization of ACM patient eligibility criteria alongside investigation of concurrent adjunctive therapies could optimize treatment of ACM with heart transplantation.
Authors
- Dimitrios V. Avgerinos (ORCID: https://orcid.org/0000-0003-2409-2184)
- Hilmi Alnsasra
- Ilias P. Doulamis (ORCID: https://orcid.org/0000-0002-4128-7111)
- Aspasia Tzani (ORCID: https://orcid.org/0000-0001-6844-2532)
- Rabea Asleh (ORCID: https://orcid.org/0000-0002-0258-7402)
- Nicholas Steudel
- Αlexandros Briasoulis (ORCID: https://orcid.org/0000-0002-5740-9670)
- S. Rastogi (ORCID: https://orcid.org/0000-0002-2067-1691)
- Ahmet Kılıç (ORCID: https://orcid.org/0000-0001-7147-8552)
- Toshiki Kuno
- Nikolaos Tepetes
Institutions
- Brigham and Women's Hospital (US)
- Mount Sinai Beth Israel (US)
- Lahey Hospital and Medical Center (US)
- Hebrew University of Jerusalem (IL)
- National and Kapodistrian University of Athens (GR)
- Hadassah Medical Center (IL)
- Lahey Medical Center (US)
- Onassis Cardiac Surgery Center (GR)
- Mayo Clinic in Florida (US)
- Johns Hopkins Hospital (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Clinical Transplantation
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1111/ctr.70343
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00